Eton Drug Patent Portfolio

Eton owns 1 orange book drug protected by 3 US patents Given below is the list of Eton's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9649280 Composition comprising hydrocortisone 12 May, 2034
Active
US9675559 Treatment of adrenal insufficiency 10 Jan, 2033
Active
US9717740 Treatment of adrenal insufficiency 19 Nov, 2032
Active


Given below is the list of recent legal activities going on the following drug patents of Eton.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Yr, Small Entity 20 Jan, 2021 US9717740
Payment of Maintenance Fee, 4th Yr, Small Entity 25 Nov, 2020 US9675559
Payment of Maintenance Fee, 4th Yr, Small Entity 04 Nov, 2020 US9649280
Mail O.P. Petition Decision 08 Sep, 2017 US9675559
Email Notification 08 Sep, 2017 US9675559
Mail-Petition Decision - Dismissed 07 Sep, 2017 US9675559
O.P. Petition Decision 06 Sep, 2017 US9675559
Petition Decision - Dismissed 06 Sep, 2017 US9675559
Petition Entered 10 Aug, 2017 US9675559
Recordation of Patent Grant Mailed 01 Aug, 2017 US9717740
Patent Issue Date Used in PTA Calculation 01 Aug, 2017 US9717740
Email Notification 21 Jul, 2017 US9717740
Application ready for PDX access by participating foreign offices 20 Jul, 2017 US9717740
PG-Pub Issue Notification 20 Jul, 2017 US9717740
Email Notification 13 Jul, 2017 US9717740


Eton's Family Patents

Eton drugs have patent protection in a total of 24 countries. It's US patent count contributes only to 6.0% of its total global patent coverage. Click below to unlock the full patent family tree.

Family Patents



Eton Drug List

Given below is the complete list of Eton's drugs and the patents protecting them.


1. Alkindi Sprinkle

Alkindi Sprinkle is protected by 3 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9649280 Composition comprising hydrocortisone 12 May, 2034
(9 years from now)
Active
US9675559 Treatment of adrenal insufficiency 10 Jan, 2033
(8 years from now)
Active
US9717740 Treatment of adrenal insufficiency 19 Nov, 2032
(8 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Alkindi Sprinkle's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List